176 related articles for article (PubMed ID: 17824361)
1. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
[TBL] [Abstract][Full Text] [Related]
2. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
[TBL] [Abstract][Full Text] [Related]
3. [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):39-54. PubMed ID: 23293270
[TBL] [Abstract][Full Text] [Related]
4. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
[TBL] [Abstract][Full Text] [Related]
5. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2010; 34(5-6 Suppl 4):35-51. PubMed ID: 21220836
[TBL] [Abstract][Full Text] [Related]
6. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2008; 32(2 Suppl 1):37-54. PubMed ID: 18770994
[TBL] [Abstract][Full Text] [Related]
7. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
[TBL] [Abstract][Full Text] [Related]
8. Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2011; 35(5-6 Suppl 5):39-54. PubMed ID: 22166349
[TBL] [Abstract][Full Text] [Related]
9. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
10. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2007; 31(2-3 Suppl 2):61-8. PubMed ID: 17824363
[TBL] [Abstract][Full Text] [Related]
11. A first survey of HPV-based screening in routine cervical cancer screening in Italy.
Ronco G; Giorgi Rossi P; Giubilato P; Del Mistro A; Zappa M; Carozzi F;
Epidemiol Prev; 2015; 39(3 Suppl 1):77-83. PubMed ID: 26405779
[TBL] [Abstract][Full Text] [Related]
12. Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.
Ronco G; Zappa M; Franceschi S; Tunesi S; Caprioglio A; Confortini M; Del Mistro A; Carozzi F; Segnan N; Zorzi M; Giorgi-Rossi P;
Eur J Cancer; 2016 Nov; 68():148-155. PubMed ID: 27755998
[TBL] [Abstract][Full Text] [Related]
13. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
14. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
15. Performance indicators of organized cervical screening in Romagna (Italy).
Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
Campari C; Fedato C; Iossa A; Petrelli A; Zorzi M; Anghinoni E; Bietta C; Brachini A; Brezzi S; Cogo C; Giordano L; Giorgi D; Palazzi M; Petrella M; Schivardi MR; Visioli CB; Giorgi Rossi P;
Eur J Cancer Prev; 2016 Jul; 25(4):321-8. PubMed ID: 26207563
[TBL] [Abstract][Full Text] [Related]
17. Time trends of process and impact indicators in Italian mammography screening programmes--1996-2004.
Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
Epidemiol Prev; 2007; 31(2-3 Suppl 2):21-32. PubMed ID: 17824360
[TBL] [Abstract][Full Text] [Related]
18. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
Zorzi M; Frayle H; Rizzi M; Fedato C; Rugge M; Penon MG; Bertazzo A; Callegaro S; Campagnolo M; Ortu F; Del Mistro A;
BJOG; 2017 Sep; 124(10):1585-1593. PubMed ID: 28120382
[TBL] [Abstract][Full Text] [Related]
19. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
[TBL] [Abstract][Full Text] [Related]
20. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
